Clinical Trial Update: A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of combining fluzoparib with apatinib and paclitaxel in patients with recurrent or metastatic gastric cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• Fluzoparib (fluzoparib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Recurrent and Metastatic Gastric Cancer | Phase 1 | Status: UNKNOWN